Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-10

Clinical Trial Update: Buprenorphine Treatment for Opioid Dependence [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating buprenorphine treatment for opioid dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Opioid Dependence | Phase 3 | Status: COMPLETED | Results posted: 2023-03-10